A groundbreaking study has revealed how obesity drug Mounjaro affects brain signals linked to cravings. Researchers observed ...

A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as ...

Researchers have identified a neural biomarker of compulsive food cravings, and showed that it is suppressed by the ...

A rare intracranial brain-recording study revealed that tirzepatide, a GLP-1 and GIP receptor agonist, temporarily silences craving-related neural activity in a key reward circuit of the brain.

The drugmaker said Monday that it has started selling higher doses of the injectable obesity treatment for $349 a month to ...

Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...

Novo Nordisk's new $199 offer for Ozempic and Wegovy aims to improve access for obesity and diabetes treatments, but experts ...

Popular drugs for diabetes and weight loss, like Ozempic, Wegovy, and Mounjaro, can have profound impacts on the body, but what about the brain? These medicines are thought to broadly suppress ...

Celebrity endorsements by Elon Musk and Serena Williams have pushed weight loss medication into the mainstream. Demand is so ...

Research reveals Eli Lilly's GLP-1 drug, tirzepatide, temporarily suppresses food cravings in a patient's brain reward center. While initial effects were promising, the impact faded over time. Results ...

The study analysed the brain of one patient on Mounjaro and saw a depletion in signals that control food cravings. | ITV ...